The Adenovirus Vaccine Live Oral Tab, cataloged under National Stock Number 6505-01-543-1311, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Gilead Sciences Inc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-543-1311 |
| Primary Part Number | TRUVADA |
| Item Name | Adenovirus Vaccine Live Oral Tab |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Gilead Sciences Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| TRUVADA TRU613010 | Gilead Sciences Pty Ltd (AUS) |
| TRUVADA-30-TABLETS | Gilead Sciences Ltd (GBR) |
| TRUVADA PRIMARY | Gilead Sciences Inc (USA) |
| Reference | Meaning |
|---|---|
| 2578367 | 5/9 Secondary reference Association Pharmaceutique Belge-Algemene Pharmaceutische Bond |
NSN 6505-01-543-1311 is a Adenovirus Vaccine Live Oral Tab, manufactured by Gilead Sciences Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-543-1311 has 3 manufacturer part numbers on file: TRUVADA TRU613010 (Gilead Sciences Pty Ltd), TRUVADA-30-TABLETS (Gilead Sciences Ltd), TRUVADA (Gilead Sciences Inc).
Key specifications for TRUVADA: Administration: ORAL; Special Features: PREGNANCY CATEGORY; B3, PERMITTEDIN SPORT, TRUVADA (TABLETS) RX (S4), TENOFOVIR DISOPROXIL FUMARATE 300 MG, EEMTRICITABINE 200 MG, LACTOSE, BLUE F-C, PACK (30), SECTION 100- HIGHLY SPECIALISED DRUGS PROGRAM:: 1 TABLET DAILYWITH FOOD; RENAL IMPAIRMENT. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.